AKITA GEOFFREY Y.,LONNING SCOTT,GREGORY RICHARD C. JR.,KUDEJ AMELIA B.
申请号：
NZ62438211
公开号：
NZ624382A
申请日:
2011.09.01
申请国别(地区):
NZ
年份:
2015
代理人:
摘要：
Disclosed is the use of an antisense or interfering RNA (RNAi) which is an antagonist of TGF-beta in the manufacture of a medicament for reducing an adverse consequence of a myocardial infarction in a patient during an acute stage of the myocardial infarction.
